Document Detail


Skin pigmentation due to minocycline treatment of facial dermatoses.
MedLine Citation:
PMID:  7654575     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Fifty-four patients taking minocycline for acne or rosacea were assessed for adverse effects. Their mean duration of treatment was 17 months, and their average cumulative dose was 47 g. No symptoms attributable to the therapy were reported. Biochemistry and haematology profiles were normal. There was no evidence of an adverse effect on thyroid function. Skin pigmentation was detected in eight patients (14.8%). Five patients had diffuse facial pigmentation, and three patients had localized pigmentation at the site of a scar or injury. Diffuse pigmentation occurred only in patients who had been on treatment for 3 years or more; 50% of such patients were affected. Age and solar damage may also have been factors in this type of pigmentation. Localized pigmentation occurred at sites of previous tissue damage, and was not directly related to the duration of therapy. Patients who receive long-term minocycline therapy should be regularly monitored for the development of pigmentation.
Authors:
C M Dwyer; A M Cuddihy; R E Kerr; R S Chapman; B F Allam
Related Documents :
2802645 - Successful treatment of severe polymorphous light eruption with azathioprine.
9030105 - Use of nasba rna amplification for detection of mycobacterium leprae in skin biopsies f...
2633615 - The role of acupuncture in asthma: changes in airways dynamics and ltc4 induced lai.
20880725 - Skin iron deposition characterises lipodermatosclerosis and leg ulcer.
285695 - The diagnosis and treatment of functional disorders of the biliary tract.
9725065 - The suspected scaphoid fracture. how useful is a unit policy?
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The British journal of dermatology     Volume:  129     ISSN:  0007-0963     ISO Abbreviation:  Br. J. Dermatol.     Publication Date:  1993 Aug 
Date Detail:
Created Date:  1995-10-02     Completed Date:  1995-10-02     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0004041     Medline TA:  Br J Dermatol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  158-62     Citation Subset:  IM    
Affiliation:
Department of Dermatology, Stobhill General Hospital, Glasgow, U.K.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acne Vulgaris / drug therapy
Adolescent
Adult
Age Factors
Aged
Cicatrix / pathology
Facial Dermatoses / drug therapy*
Female
Humans
Male
Middle Aged
Minocycline / administration & dosage,  adverse effects*
Pigmentation Disorders / chemically induced*,  pathology
Rosacea / drug therapy
Skin Aging
Skin Pigmentation / drug effects
Thyroid Gland / drug effects
Thyrotropin / blood
Thyroxine / analysis
Time Factors
Chemical
Reg. No./Substance:
10118-90-8/Minocycline; 7488-70-2/Thyroxine; 9002-71-5/Thyrotropin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quantification of hydrogen peroxide generation by Granuflex (DuoDERM) Hydrocolloid Granules and its ...
Next Document:  The efficacy of psoralen photochemotherapy in the treatment of aquagenic pruritus.